AMN Healthcare Services NYSE: AMN reported higher third-quarter revenue as demand for travel nurses and allied healthcare professionals grew, while a favorable adjustment tied to past labor disruptions also boosted results.

AMN's revenue recovered to $717.3M in 2026Q3, up 13.0% year-over-year, and gross margin widened to 31.9%, suggesting clinician staffing demand is stabilizing after its post-pandemic trough.
Price trend, volume and key moving averages
Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 5, 2026 | $1.16+406.1% vs $0.23 | $717M+10.4% vs $650M |
Q3 2026 Aug 6, 2026 | $0.77+307.8% vs $0.19 | $673M+7.1% vs $628M |
Q2 2026 May 7, 2026 | $2.10+31.3% vs $1.60 | $1.4B+11.7% vs $1.2B |
Q1 2026 Feb 19, 2026 | $0.22+0.0% vs $0.22 | $748M+3.4% vs $724M |
AMN Healthcare Services NYSE: AMN reported higher third-quarter revenue as demand for travel nurses and allied healthcare professionals grew, while a favorable adjustment tied to past labor disruptions also boosted results.

AMN Healthcare Services, Inc. ( AMN ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Randle Reece - Senior Director of Investor Relations & Strategy Caroline Grace - President, CEO & Director Brian Scott - CFO & COO Conference Call Participants Trevor Romeo Jeffrey Silber - BMO Capital Markets Equity Research Kevin Fischbeck - BofA Securities, Research Division Albert Rice - UBS Investment Bank, Research Division Constantine Davides - Citizens JMP Securities, LLC, Research Division Tobey Sommer - Truist Securities, Inc., Research Division Jack Slevin - Jefferies LLC, Research Division Mark Marcon - Robert W. Baird & Co. Incorporated, Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the AMN Healthcare Third Quarter 2026 Earnings Conference Call.

Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Quarterly revenue of $717 million and adjusted EBITDA of $94 million; GAAP net income of $0.83/share and adjusted EPS of $1.16 DALLAS, Nov. 5, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2026 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.
Benchmark AMN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for AMN Healthcare Services, Inc. (AMN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $38.10 | $1.48B | 14.04 | -8.49% | 3.1% | 15.19% | — | |
| $546.75 | $7.26B | 25.43 | 4.06% | 10.61% | 32.1% | 0.4% | |
| $11.82 | $359.38M | -8.49 | 3.1% | -2.55% | -17.28% | — | |
| $24.69 | $1.69B | 16.33 | 7.08% | 5.58% | 20.22% | — | |
| $64.39 | $3.38B | 9.21 | 2.36% | 7.07% | 21.72% | 1.84% | |
| $31.63 | $4.97B | 22.12 | 13.03% | 3.74% | 16.36% | — |
AMN Healthcare Services, Inc. (AMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
AMN Healthcare Services, Inc. (AMN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 5, 2026·SEC
Aug 6, 2026·SEC
May 7, 2026·SEC
Get notified when AMN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AMN Healthcare Services, Inc. (AMN) stock FAQ — growth, dividends, profitability & financials explained
AMN Healthcare Services, Inc. (AMN) reported $3.52B in revenue over the trailing twelve months. Revenue was $2.73B in fiscal year 2025. That is 1083% more than the $230.8M of fiscal year 2000.
AMN Healthcare Services, Inc. (AMN) grew revenue by 29.5% over the trailing twelve months, compared with the twelve months before.
Yes. AMN Healthcare Services, Inc. (AMN) earned $109.0M in net income over the trailing twelve months (a 3.1% net margin).
AMN Healthcare Services, Inc. (AMN) had a return on equity (ROE) of 15.2% over the trailing twelve months. That is above the market's typical 10-15%.
AMN Healthcare Services, Inc. (AMN) generated $327.0M in free cash flow over the trailing twelve months.